Larimar Therapeutics (LRMR) Financials: Revenue & Earnings

LRMR price $2.52 +0.12 +5.23%

Ticker
LRMR
Price
$2.52
Change
+0.12 +5.23%
Market cap ?
$261.27M
P/E ?
-1.14
Forward P/E ?
4.84
Dividend yield ?
0.00%
Beta ?
0.69
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
59
Quality
51
Growth
100

Stocklytics score rationale: value 59, quality 51, growth 100.

Financials

2016201720182019202020212022202320242025
0000000000

Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat…

Fair value

LRMR fair value $20.33. Price $2.52. Price is 88% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare LRMR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.35——
2026-08-04-0.30-0.38——
2026-05-14-0.31-0.53——
2026-03-19-0.73-0.44——
2025-11-05-0.61-0.39——
2025-08-14-0.41-0.47——
2025-04-30-0.46-0.42——
2025-03-24-0.45-0.29241.00K—
2024-10-30-0.24-0.37——
2024-08-07-0.34-0.32——
2024-05-09-0.27-0.24——
2024-03-14-0.30-0.25——
2023-11-14-0.21-0.23——
2023-08-10-0.19-0.21——
2023-05-15-0.15-0.25——
2023-03-14-0.21-0.78——
2022-11-10-0.37-0.50——
2022-08-11-0.47-0.62——
2022-05-12-0.49-0.62——
2022-03-25-0.50-0.72——
2021-11-12-0.92-0.62——
2021-08-12-0.79-0.73——
2021-05-10-0.76-0.93——
2021-03-04-0.89-0.72——
2020-11-10-0.64———
2020-08-11-1.21———
2020-05-08-1.20———
2020-03-05-2.28-2.28——
2019-11-06-2.88-3.20——
2019-08-08-3.84-4.38——
2019-05-09-4.20-5.09——
2019-03-11-4.68-5.26——
2018-11-07-4.92-5.64——
2018-08-07-6.84-7.08——
2018-05-08-6.96-6.18——
2018-03-06-5.76-6.84——
2017-11-07-5.52-6.92——
2017-08-08-5.88-6.24——
2017-05-09-5.76-5.21——
2017-03-09-4.56-6.03——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-29Harlow John B. Jr.Buy800.00K$3.142.51M
2026-09-29Harlow John B. Jr.Buy50.00K——
2026-09-29Harlow John B. Jr.Other0——
2026-07-06Hamilton Thomas EdwardBuy50.00K$3.34166.89K
2026-05-19Flynn James EBuy55.15K$3.33183.65K
2026-05-19LEFF JONATHAN SBuy55.15K$3.33183.65K
2026-05-19SHERMAN JEFFREY WBuy55.15K$3.33183.65K
2026-05-19Truitt JosephBuy55.15K$3.33183.65K
2026-05-19THOMAS FRANK EBuy55.15K$3.33183.65K
2026-05-19Hamilton Thomas EdwardBuy55.15K$3.33183.65K
2026-02-27Flynn James EBuy1.08M$5.005.42M
2026-02-27Flynn James EBuy1.08M$5.005.42M
2026-02-27Flynn James EBuy831.98K$5.004.16M
2026-02-27Flynn James EBuy2.00M$5.0010.00M
2026-02-27Hamilton Thomas EdwardBuy100.00K$5.00500.00K
2026-02-27THOMAS FRANK EBuy5.00K$5.0025.00K
2026-02-27SHERMAN JEFFREY WBuy5.00K$5.0025.00K
2026-01-26Shankar GopiBuy153.82K$3.60553.76K
2026-01-26Shankar GopiBuy25.64K——
2026-01-26Clayton RussellBuy153.82K$3.60553.76K
2026-01-26Clayton RussellBuy25.64K——
2026-01-26BEN-MAIMON CAROLEBuy600.60K$3.602.16M
2026-01-26BEN-MAIMON CAROLEBuy100.10K——
2026-01-26Celano MichaelBuy225.62K$3.60812.24K
2026-01-26Celano MichaelBuy37.60K——
2025-07-31Flynn James EBuy3.39M$3.2010.84M
2025-07-31Flynn James EBuy3.39M$3.2010.84M
2025-07-31Flynn James EBuy2.60M$3.208.32M
2025-05-13Flynn James EBuy19.00K$1.8835.62K
2025-05-13SHERMAN JEFFREY WBuy19.00K$1.8835.62K
2025-05-13Truitt JosephBuy19.00K$1.8835.62K
2025-05-13Hamilton Thomas EdwardBuy19.00K$1.8835.62K
2025-05-13THOMAS FRANK EBuy19.00K$1.8835.62K
2025-05-13LEFF JONATHAN SBuy19.00K$1.8835.62K
2025-01-22Shankar GopiBuy139.84K$3.46483.84K
2025-01-22Shankar GopiBuy23.31K——
2025-01-22Clayton RussellBuy139.84K$3.46483.84K
2025-01-22Clayton RussellBuy23.31K——
2025-01-22BEN-MAIMON CAROLEBuy546.00K$3.461.89M
2025-01-22BEN-MAIMON CAROLEBuy91.00K——
2025-01-22Celano MichaelBuy205.11K$3.46709.68K
2025-01-22Celano MichaelBuy34.19K——
2024-05-29Flynn James EBuy19.00K$7.07134.33K
2024-05-29THOMAS FRANK EBuy19.00K$7.07134.33K
2024-05-29LEFF JONATHAN SBuy19.00K$7.07134.33K
2024-05-29SHERMAN JEFFREY WBuy19.00K$7.07134.33K
2024-05-29Truitt JosephBuy19.00K$7.07134.33K
2024-05-29Hamilton Thomas EdwardBuy19.00K$7.07134.33K
2024-02-16Hamilton Thomas EdwardBuy57.21K$8.74500.00K
2024-02-16Flynn James EBuy1.43M$8.7412.50M
2024-02-16Flynn James EBuy1.43M$8.7412.50M
2024-02-16Flynn James EBuy1.43M$8.7412.50M
2024-02-14THOMAS FRANK EBuy2.00K$11.0022.00K
2024-01-17Shankar GopiBuy135.00K$4.21568.35K
2024-01-17Shankar GopiBuy22.50K——
2024-01-17Celano MichaelBuy187.50K$4.21789.38K
2024-01-17Celano MichaelBuy31.25K——
2024-01-17Clayton RussellBuy135.00K$4.21568.35K
2024-01-17Clayton RussellBuy22.50K——
2024-01-17BEN-MAIMON CAROLEBuy396.75K$4.211.67M
2024-01-17BEN-MAIMON CAROLEBuy66.12K——
2023-12-07Shankar GopiBuy5.00K$3.7318.66K
2023-10-03SHERMAN JEFFREY WBuy16.60K$3.5659.01K
2023-10-03SHERMAN JEFFREY WOther0——
2023-07-17Clayton RussellBuy180.00K$3.22579.60K
2023-07-17Clayton RussellOther0——
2023-05-17Celano MichaelBuy5.00K$3.7318.63K
2023-05-17BEN-MAIMON CAROLEBuy5.00K$3.7118.52K
2023-05-17Truitt JosephBuy2.75K$3.7310.26K
2023-05-09Flynn James EBuy8.30K$5.0942.25K
2023-05-09Truitt JosephBuy8.30K$5.0942.25K
2023-05-09Hamilton Thomas EdwardBuy8.30K$5.0942.25K
2023-05-09LEFF JONATHAN SBuy8.30K$5.0942.25K
2023-05-09THOMAS FRANK EBuy8.30K$5.0942.25K
2023-02-07Shankar GopiBuy180.00K$5.881.06M
2023-02-07Shankar GopiOther0——
2023-01-31Celano MichaelBuy120.00K$4.94592.80K
2023-01-31Celano MichaelBuy76.00K——
2023-01-31BEN-MAIMON CAROLEBuy325.00K$4.941.61M
2023-01-31BEN-MAIMON CAROLEBuy205.00K——
2022-09-16Flynn James EBuy2.78M$3.158.75M
2022-09-16Flynn James EBuy2.78M$3.158.75M
2022-09-16Flynn James EBuy2.78M$3.158.75M
2022-09-16Flynn James EBuy2.78M$3.158.75M
2022-09-16DEERFIELD PARTNERS, L.P.Sell0——
2022-09-16Hamilton Thomas EdwardBuy317.46K$3.151000.00K
2022-09-16Celano MichaelBuy31.75K$3.15100.00K
2022-09-16BEN-MAIMON CAROLEBuy31.75K$3.15100.00K
2022-05-10BEN-MAIMON CAROLEBuy40.00K$2.92116.80K
2022-05-10BEN-MAIMON CAROLEBuy40.00K——
2022-05-10Celano MichaelBuy20.00K——
2022-05-10Celano MichaelBuy20.00K$2.9258.40K
2022-05-10Truitt JosephBuy8.30K$2.9224.24K
2022-05-10Truitt JosephBuy8.30K——
2022-05-10Barrett PeterBuy8.30K——
2022-05-10Hamilton Thomas EdwardBuy8.30K——
2022-05-10LEFF JONATHAN SBuy8.30K——
2022-05-10THOMAS FRANK EBuy8.30K——
2022-05-10Flynn James EBuy8.30K$2.9224.24K
2022-05-10DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Buy8.30K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 171, holders +1 vs prior quarter. Ownership 92.37%.

HolderSharesChangeChange %Value
DEERFIELD MANAGEMENT COMPANY, L.P.35.61M00.00%108.60M
BLUE OWL CAPITAL HOLDINGS LP9.16M2.04M+28.70%27.95M
BLACKROCK, INC.5.68M1.93M+51.33%17.32M
DEFILADE CAPITAL MANAGEMENT, L.P.3.67M3.67MNew11.19M
DRIEHAUS CAPITAL MANAGEMENT LLC3.16M229.02K+7.80%9.65M
VANGUARD CAPITAL MANAGEMENT LLC2.97M108.55K+3.79%9.07M
RTW INVESTMENTS, LP2.57M1.07M+71.07%7.83M
AQR CAPITAL MANAGEMENT LLC2.37M1.55M+190.08%7.23M
MARSHALL WACE, LLP2.01M1.08M+115.59%6.14M
DAFNA CAPITAL MANAGEMENT LLC2.01M-21.00K-1.03%6.12M
GOLDMAN SACHS GROUP INC1.75M1.66M+1847.68%5.35M
GEODE CAPITAL MANAGEMENT, LLC1.68M570.24K+51.43%5.12M
QUBE RESEARCH & TECHNOLOGIES LTD1.64M793.40K+93.60%5.01M
CITADEL ADVISORS LLC1.46M1.42M+4424.30%4.44M
STATE STREET CORP1.41M500.48K+54.92%4.31M
VANGUARD PORTFOLIO MANAGEMENT LLC1.40M996.61K+245.13%4.28M
WOODLINE PARTNERS LP1.40M00.00%4.27M
MILLENNIUM MANAGEMENT LLC1.33M-2.29M-63.23%4.07M
DIMENSIONAL FUND ADVISORS LP961.08K162.62K+20.37%2.93M
FMR LLC937.37K873.80K+1374.54%2.86M
SPHERA FUNDS MANAGEMENT LTD.926.00K926.00KNew2.82M
NUVEEN, LLC895.30K220.39K+32.65%2.73M
ALYESKA INVESTMENT GROUP, L.P.617.21K00.00%1.88M
NORTHERN TRUST CORP550.27K173.76K+46.15%1.68M
SUSQUEHANNA INTERNATIONAL GROUP, LLP518.30K378.24K+270.06%1.58M

Earnings and financials

Larimar Therapeutics, Inc. (LRMR) trades at $2.52, with a market cap of $261.27M and a trailing P/E of -1.14. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Larimar Therapeutics (LRMR) Financials: Revenue & Earnings

LRMR$2.52+0.12 +5.23%

$261.27M

Market Cap

-1.14

P/E

4.84

Forward P/E

70

Score

Price History